我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

腹型肥胖患者体脂分布与代谢综合征及冠状动脉病变的关系

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2018年第1期
页码:
40-043,052
栏目:
临床研究
出版日期:
2017-10-10

文章信息/Info

Title:
Fat distribution in abdominal obesity and its relationship to metabolic syndrome and coronary artery disease
作者:
贺秀华1田 刚12
(1.许昌市中心医院心内科,河南 许昌 461000;2.西安交通大学第一附属医院心内科,陕西 西安 710061)
Author(s):
HE Xiu-hua1 TIAN Gang2
(1.Department of Cardiology, Xuchang Central Hospital, Xuchang 461000, Henan, China; 2.Department of Cardiology, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, Shaanxi, China)
关键词:
肥胖腹型体脂分布代谢综合征冠状动脉病变
Keywords:
abdominal obesity fat distribution metabolic syndrome coronary artery diseases
分类号:
R543.3
DOI:
-
文献标识码:
A
摘要:
目的 探讨腹型肥胖患者各部位脂肪分布与代谢综合征(MS)和冠状动脉病变(CAD)的关系。方法 57例腹型肥胖患者,采用GE64层螺旋CT评估腹部、心脏及冠脉周围脂肪分布情况,超声评估肾脏周围脂肪分布情况,同时测量血生化指标、体质量指数和腰臀比等。结果 ①MS组VAT、肾短轴脂肪面积及Gessini积分显著高于单纯肥胖组〔分别为(2290±601) cc vs.(3024±792) cc;(13.4±1.1) mm2 vs.(18.8±2.2) mm2;(20±3) vs.(46±6);P<0.05,P<0.01〕;多因素Logistic回归分析显示VAT是MS的独立危险因素(OR=1.002,95%CI 1.000-1.003,P<0.05);②Gessini评分>80分组WHR、MS异常代谢组分个数、糖尿病比例、CYS-C、EAT、冠脉周围脂肪厚度均显著高于Gessini评分40~80分组及Gessini评分<40分组〔分别为(1.10±0.01) vs.(0.96±0.01)、(0.96±0.01);(4.38±0.38) vs.(3.35±0.27)、(2.71±0.27);71% vs. 17%、6%;(1.33±0.21) mg/L vs.(1.03±0.07) mg/L、(0.86±0.04) mg/L;(217±58) cc vs.(201±18) cc、(129±18) cc;(17.0±1.2) mm vs.(14.3±0.6) mm、(10.4±0.6) mm;P<0.05,P<0.01〕。多因素逐步回归分析显示,MS异常代谢组分个数、CYS-C、冠脉周围脂肪厚度是影响冠脉病变程度的危险因素。结论 肥胖患者体内不同部位的脂肪沉积对其代谢、心血管疾病的作用具有差异性;在明显肥胖患者中,心脏及冠脉周围脂肪分布可能是更重要的心血管危险因子。
Abstract:
AIM To describe the characteristics of fat distribution in obesity and to explore its relationship to the occurrence and severity of metabolic disorder and coronary artery diseases. METHODS Fifty-seven patients (43 males and 14 females) with definite abdominal obesity, mean age of 52.44±11.47 yeas were included in this study. Fat accumulation in heart, aorta and abdominal viscera were quantified by 64-slice computer tomography. Peri-renal fat accumulation was measured by ultrasound. Traditional cardiovascular risk factors and metabolic risk factors were also examined. RESULTS VAT, peri-renal fat and Gessini score were significantly larger in patients with metabolic syndrome (MS) than those without [(2290±601) cc versus.(3024±792) cc; (13.4±1.1) mm2 vs.(18.8±2.2) mm2; (20±3) vs.(46±6); P<0.05, P<0.01]. VAT was significantly associated with the pressence of MS by multivariate logistic regression (OR=1.002, 95%CI 1.000-1.003, P<0.05). WHR, number of MS components, diabetes mellitus, CYS-C, EAT and pericoronary adipose tissue in Gessini score>80 group were significantly higher than those in Gessini score 40~80 group and Gessini score<40 group [(1.10±0.01) vs.(0.96±0.01), (0.96±0.01);(4.38±0.38) vs.(3.35±0.27), (2.71±0.27); 71% vs. 17%, 6%; (1.33±0.21) mg/L vs.(1.03±0.07 ) mg/L, (0.86±0.04) mg/L; (217±58) cc vs.(201±18) cc, (129±18) cc; (17.0±1.2) mm vs.(14.3±0.6) mm, (10.4±0.6) mm; P<0.05, P<0.01]. Multivariate stepwise regression analysis showed a significant relationship between Gessini score and MS, pericoronary adipose tissue thickness and cystatin. CONCLUSION Varying locations of body fat distribution play different roles in obesity-related metabolic cardiovascular disease in abdominal obesity.

参考文献/References

[1]Achike FI,To N,Wang HD,et al.Obesity, metabolic syndrome, adipocytes and vascular function: A holistic viewpoint[J].Clin Exp Pharmacol Physiol,2011,38(1):1-10.

[2]Ouwens DM,Sell H,Greulich S,et al.The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease[J].J Cell Mol Med,2010,14(9):2223-2234.

[3]李传战,孔秋菊.冠心病患者肥胖时程的影响因素[J].心脏杂志,2007,19(1):118.

[4]Fox CS,Massaro JM,Hoffmann U,et al.Abdominal visceral and subcutaneous adipose tissue compartments-Association with metabolic risk factors in the Framingham Heart Study[J].Circulation,2007,116(1):39-48.

[5]Ibrahim MM.Subcutaneous and visceral adipose tissue:structural and functional differences[J].Obesity Reviews,2010,11(1):11-18.

[6]Neeland IJ,Turer AT,Ayers CR,et al.Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults[J].JAMA,2012,308(11):1150-1159.

[7]Lee S,Kuk JL,Kim Y,et al.Measurement site of visceral adipose tissue and prediction of metabolic syndrome in youth[J].Pediatr Diabetes,2011,12(3 Pt 2):250-257.

[8]Antonopoulos AS,Antoniades C.The role of epicardial adipose tissue in cardiac biology:classic concepts and emerging roles[J].J Physiol,2017,595(12):3907-3917.

[9]Gorter PM,van Lindert A,de Vos AM,et al.Quantification of epicardial and peri-coronary fat using cardiac computed tomography;reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease[J].Atherosclerosis,2008,197(2):896-903.

[10]Lehman SJ,Massaro JM,Schlett CL,et al.Peri-aortic fat,cardiovascular disease risk factors,and aortic calcification:the Framingham Heart Study[J].Atherosclerosis,2010,210(2):656-661.

[11]Rosito GA,Massaro JM,Hoffmann U,et al.Pericardial fat,visceral abdominal fat,cardiovascular disease risk factors,and vascular calcification in a community-based sample:the Framingham Heart Study[J].Circulation,2008,117(5):605-613.

[12]Mahabadi AA,Massaro JM,Rosito GA,et al.Association of pericardial fat,intrathoracic fat,and visceral abdominal fat with cardiovascular disease burden:the Framingham Heart Study[J].Eur Heart J,2009,30(7):850-856.

备注/Memo

备注/Memo:
收稿日期:2017-01-24.基金项目:国家自然科学基金项目资助(30871042) 作者简介:贺秀华,主治医师,硕士 Email:hexiuhua0116@163.com
更新日期/Last Update: 1900-01-01